Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

HUMA

name pending profile ingest

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
10Tracked holders
Δ holders
6.78MShares held
$32.52MReported value
+0New positions
−0Exits
How these are computed → Explain this at the Research Desk →

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 58 -6 41.95M $32.73M +7 −13
Q1 2026 65 +2 40.01M $24.33M +9 −7
Q4 2025 63 +1 48.26M $46.36M +1
Q3 2025 14 0 30.19M $52.54M
Q2 2025 11 -1 32.34M $67.60M −1
Q1 2025 9 0 11.73M $20.00M
Q4 2024 9 -1 9.15M $46.21M −1
Q3 2024 9 -1 5.62M $30.59M −1
Q2 2024 10 6.78M $32.52M
Holder count
Who holds it · Q2 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Geode Capital Management (passive) 1.86M $8.93M 0.0% n/c 1 SEC ↗
2 Geode Capital Management (passive) 1.86M $8.93M 0.0% n/c 1 SEC ↗
3 Millennium Management 1.60M $7.68M 0.0% n/c 1 SEC ↗
4 Two Sigma Investments 1.14M $5.48M 0.0% n/c 1 SEC ↗
5 Renaissance Technologies 600.30K $2.88M 0.0% n/c 1 SEC ↗
6 D. E. Shaw & Co. 585.96K $2.81M 0.0% n/c 1 SEC ↗
7 Marshall Wace 463.66K $2.23M 0.0% n/c 1 SEC ↗
8 Marshall Wace 463.66K $2.23M 0.0% n/c 1 SEC ↗
9 AQR Capital Management 256.34K $1.23M 0.0% n/c 1 SEC ↗
10 AQR Capital Management 256.34K $1.23M 0.0% n/c 1 SEC ↗
11 AQR Capital Management 256.34K $1.23M 0.0% n/c 1 SEC ↗
12 Wellington Management 194.32K $932,755 0.0% n/c 1 SEC ↗
13 Wellington Management 194.32K $932,755 0.0% n/c 1 SEC ↗
14 Citadel Advisors 43.90K $210,730 0.0% n/c 1 SEC ↗
15 T. Rowe Price 28.07K $135,000 0.0% n/c 1 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

No new tracked buyers this quarter.

Exited

No tracked exits this quarter.

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 156 holders, 58.93M shares, $35.57M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Insider transactions

Open-market purchases (P)

Aug 20 Jones Keith Anthony

Director · 10.00K sh @ 0.693 · $6,930

Aug 17 Jones Keith Anthony

Director · 30.00K sh @ 0.594 · $17,820

Open-market sales (S)

No open-market insider sales in our coverage window.

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Beneficial ownership
Aug 18 SC 13D/A — FRESENIUS MEDICAL CARE HOLDINGS INC /NY/

4.9% of class · View original SEC filing ↗

Jul 28 SC 13G/A — BlackRock, Inc.

View original SEC filing ↗

Jul 13 SC 13D/A — FRESENIUS MEDICAL CARE HOLDINGS INC /NY/

6.8% of class · View original SEC filing ↗

Jun 22 SC 13G — DAVIDSON KEMPNER CAPITAL MANAGEMENT LP

View original SEC filing ↗

Jun 15 SC 13D/A — FRESENIUS MEDICAL CARE HOLDINGS INC /NY/

6.8% of class · View original SEC filing ↗

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q2 2024 · Methodology · Get this via the API